MARKER THERAPEUTICS, INC. Accumulated Other Comprehensive Income
MARKER THERAPEUTICS, INC. (MRKR) had Accumulated Other Comprehensive Income of -$59.58 thousand as of 2014-03-31, per its 10-Q/A filed 2014-05-21.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2014-05-21
- 2014-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$59.58K.
- 2013-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$58.33K.
- 2013-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$59.84K.
- 2013-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$58.44K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2014-03-31 | -$59.58K 10-Q/A · filed 2014-05-21 |
| 2013-12-31 | -$58.33K 10-Q/A · filed 2014-05-21 |
| 2013-09-30 | -$59.84K 10-Q · filed 2013-11-19 |
| 2013-03-31 | -$58.44K 10-Q · filed 2013-08-19 |
| 2012-12-31 | -$61.65K 10-K/A · filed 2014-04-17 |
| 2012-09-30 | -$63.08K 10-Q · filed 2012-11-19 |
| 2012-06-30 | -$60.19K 10-Q/A · filed 2012-09-12 |
| 2012-03-31 | -$62.10K 10-Q · filed 2012-05-21 |
| 2011-12-31 | -$60.53K 10-K · filed 2013-05-15 |
| 2011-09-30 | -$58.61K 10-Q · filed 2011-11-21 |
| 2011-06-30 | -$62.46K 10-Q · filed 2011-08-22 |
| 2010-12-31 | -$60.90K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |